Clinical trial
TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy
NCT00608023
Study timeline
Study start (unknown)2007-08-01Date precision: month
Registry last updated2022-09-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lipodystrophyunresolved
HIV Infectionsunresolved
Interventions
Sponsors & collaborators
Theratechnologieslead sponsor
Mapped research locations
LondonUnited Kingdom4San FranciscoCalifornia, United States3BostonMassachusetts, United States2ChicagoIllinois, United States2TorontoOntario, Canada2MadridSpain2ParisFrance2New YorkNew York, United States1Los AngelesCalifornia, United States1DallasTexas, United States1AtlantaGeorgia, United States1SeattleWashington, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00608023 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.